IRVINE, Calif.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today reported that an overview of the Company’s business strategy will be given at the UBS Global Life Sciences Conference, being held at the Grand Hyatt Hotel in New York City. The Spectrum Pharmaceuticals presentation is at 8:30 a.m. Eastern Time on Wednesday, September 22, 2010.
